252 related articles for article (PubMed ID: 35908851)
1. Marburg virus disease: A deadly rare virus is coming.
Zhao F; He Y; Lu H
Biosci Trends; 2022 Sep; 16(4):312-316. PubMed ID: 35908851
[TBL] [Abstract][Full Text] [Related]
2. Reemergence of Marburgvirus disease: Update on current control and prevention measures and review of the literature.
Elsheikh R; Makram AM; Selim H; Nguyen D; Le TTT; Tran VP; Elaziz Khader SA; Huy NT
Rev Med Virol; 2023 Sep; 33(5):e2461. PubMed ID: 37208958
[TBL] [Abstract][Full Text] [Related]
3. Marburg Virus Outbreak in Equatorial Guinea: Need for Speed.
Ezie KN; Takoutsing BD; Modeste D; Ines MZ; Sybile TNL; Caleb NM; Esene IN
Ann Glob Health; 2024; 90(1):5. PubMed ID: 38273871
[TBL] [Abstract][Full Text] [Related]
4. Knowledge and attitude towards Ebola and Marburg virus diseases in Uganda using quantitative and participatory epidemiology techniques.
Nyakarahuka L; Skjerve E; Nabadda D; Sitali DC; Mumba C; Mwiine FN; Lutwama JJ; Balinandi S; Shoemaker T; Kankya C
PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005907. PubMed ID: 28892520
[TBL] [Abstract][Full Text] [Related]
5. Marburg and Ebola--arming ourselves against the deadly filoviruses.
Peters CJ
N Engl J Med; 2005 Jun; 352(25):2571-3. PubMed ID: 15972860
[No Abstract] [Full Text] [Related]
6. Developing a vaccine against Marburg virus disease.
Manno D
Lancet; 2023 Jan; 401(10373):251-253. PubMed ID: 36709065
[No Abstract] [Full Text] [Related]
7. Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.
Matassov D; Mire CE; Latham T; Geisbert JB; Xu R; Ota-Setlik A; Agans KN; Kobs DJ; Wendling MQS; Burnaugh A; Rudge TL; Sabourin CL; Egan MA; Clarke DK; Geisbert TW; Eldridge JH
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142131
[TBL] [Abstract][Full Text] [Related]
8. A mathematical model of Marburg virus disease outbreaks and the potential role of vaccination in control.
Qian GY; Edmunds WJ; Bausch DG; Jombart T
BMC Med; 2023 Nov; 21(1):439. PubMed ID: 37964296
[TBL] [Abstract][Full Text] [Related]
9. [Ebola and Marburg hemorrhagic fever viruses: update on filoviruses].
Leroy E; Baize S; Gonzalez JP
Med Trop (Mars); 2011 Apr; 71(2):111-21. PubMed ID: 21695865
[TBL] [Abstract][Full Text] [Related]
10. Ebola and Marburg haemorrhagic fever.
Rougeron V; Feldmann H; Grard G; Becker S; Leroy EM
J Clin Virol; 2015 Mar; 64():111-9. PubMed ID: 25660265
[TBL] [Abstract][Full Text] [Related]
11. Development of vaccines for Marburg hemorrhagic fever.
Bausch DG; Geisbert TW
Expert Rev Vaccines; 2007 Feb; 6(1):57-74. PubMed ID: 17280479
[TBL] [Abstract][Full Text] [Related]
12. [Ebola and Marburg viruses: the humans strike back].
Alazard-Dany N; Ottmann Terrangle M; Volchkov V
Med Sci (Paris); 2006 Apr; 22(4):405-10. PubMed ID: 16597410
[TBL] [Abstract][Full Text] [Related]
13. [Marburg and Ebola hemorrhagic fevers--pathogens, epidemiology and therapy].
Stock I
Med Monatsschr Pharm; 2014 Sep; 37(9):324-30; quiz 331-2. PubMed ID: 25282746
[TBL] [Abstract][Full Text] [Related]
14. Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.
Geisbert TW; Geisbert JB; Leung A; Daddario-DiCaprio KM; Hensley LE; Grolla A; Feldmann H
J Virol; 2009 Jul; 83(14):7296-304. PubMed ID: 19386702
[TBL] [Abstract][Full Text] [Related]
15. Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates.
Suschak JJ; Schmaljohn CS
Hum Vaccin Immunother; 2019; 15(10):2359-2377. PubMed ID: 31589088
[TBL] [Abstract][Full Text] [Related]
16. Lessons learned during active epidemiological surveillance of Ebola and Marburg viral hemorrhagic fever epidemics in Africa.
Allaranga Y; Kone ML; Formenty P; Libama F; Boumandouki P; Woodfill CJ; Sow I; Duale S; Alemu W; Yada A
East Afr J Public Health; 2010 Mar; 7(1):30-6. PubMed ID: 21413569
[TBL] [Abstract][Full Text] [Related]
17. Pathogenicity and virulence of Marburg virus.
Abir MH; Rahman T; Das A; Etu SN; Nafiz IH; Rakib A; Mitra S; Emran TB; Dhama K; Islam A; Siyadatpanah A; Mahmud S; Kim B; Hassan MM
Virulence; 2022 Dec; 13(1):609-633. PubMed ID: 35363588
[TBL] [Abstract][Full Text] [Related]
18. Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections.
Geisbert TW; Feldmann H
J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S1075-81. PubMed ID: 21987744
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions.
Bausch DG; Sprecher AG; Jeffs B; Boumandouki P
Antiviral Res; 2008 Apr; 78(1):150-61. PubMed ID: 18336927
[TBL] [Abstract][Full Text] [Related]
20. A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates.
Hunegnaw R; Honko AN; Wang L; Carr D; Murray T; Shi W; Nguyen L; Storm N; Dulan CNM; Foulds KE; Agans KN; Cross RW; Geisbert JB; Cheng C; Ploquin A; Stanley DA; Geisbert TW; Nabel GJ; Sullivan NJ
Sci Transl Med; 2022 Dec; 14(675):eabq6364. PubMed ID: 36516269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
